Anghui Peng
Impact in
-
- Cancer Genomics and Diagnostics
-
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
- Single-cell and spatial transcriptomics
- Protein Degradation and Inhibitors
Papers in
-
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Histone Deacetylase Inhibitors Research 1
- Single-cell and spatial transcriptomics 1
- Oncology 3
- Co-authors
- Yihao Sun (3 shared papers)Hao Zhao (2 shared papers)Ruiqi Wang (2 shared papers)Wenting Li (1 shared paper)Xumei Ouyang (1 shared paper)Ying-Yin Chen (1 shared paper)Jiawei Zhong (1 shared paper)Shuxin Fan (1 shared paper)
In The Last Decade
Anghui Peng
8 papers receiving 257 citations
Anghui Peng's Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 45
- Molecular Biology 162
- Immunology 41
- Oncology 36
- Biomaterials 13
Countries citing papers authored by Anghui Peng
This map shows the geographic impact of Anghui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anghui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anghui Peng more than expected).
Fields of papers citing papers by Anghui Peng
This network shows the impact of papers produced by Anghui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anghui Peng. The network helps show where Anghui Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Anghui Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer epigenetics: from laboratory studies and clinical trials to precision medicine Hit paper breakdown → | 2024 | 129 |
| 2 | 2019 | 44 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 23 | |
| 5 | 2023 | 14 | |
| 6 | 2022 | 13 | |
| 7 | 2023 | 4 | |
| 8 | 2019 | 1 |
About Anghui Peng
Anghui Peng is a scholar working on Molecular Biology, Oncology, Immunology, Infectious Diseases and Surgery, having authored 8 papers that have together received 260 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (1 paper), Cancer Genomics and Diagnostics (1 paper), Immunotherapy and Immune Responses (1 paper), Protein Degradation and Inhibitors (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Single-cell and spatial transcriptomics (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (45 citations), Molecular Biology (162 citations), Immunology (41 citations), Oncology (36 citations) and Biomaterials (13 citations). Anghui Peng has collaborated with scholars based in China and Macao. Frequent co-authors include Yihao Sun, Hao Zhao, Ruiqi Wang, Wenting Li, Xumei Ouyang, Ying-Yin Chen, Jiawei Zhong, Shuxin Fan, Youjin Hu and Shanshan Chen. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, PROTEOMICS, Cell Death Discovery and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.